Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger
1. Kimberly-Clark to acquire Kenvue for over $40 billion. 2. The deal offers annual savings of $2.1 billion. 3. Kenvue faces legal challenges impacting investor sentiment. 4. Acquisition expected to be finalized in late 2026. 5. Combining revenues will total approximately $32 billion.